Literature DB >> 656245

Red cell survival after aortic valve replacement with Björk-Shiley prosthesis in presence of sickle-cell trait.

P W Wenham, G L Scott, J D Wisheart.   

Abstract

A case of aortic valve replacement with a Björk-Shiley disc prosthesis in a patient with sickle-cell trait is presented. Six months after operation red cell survival was not significantly reduced. On theoretical and clinical grounds it is concluded that the presence of sickle-cell trait does not contribute to late postoperative haemolysis after heart valve replacement.

Entities:  

Mesh：

Year:  1978        PMID： 656245      PMCID： PMC483471          DOI： 10.1136/hrt.40.6.703

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  10 in total

1.  Radioactive sodium chromate for the study of survival of red blood cells. III. The abnormal hemoglobin syndromes.

Authors:  I M WEINSTEIN; C L SPURLING; H KLEIN; T F NECHELES
Journal:  Blood       Date:  1954-12       Impact factor: 22.113

2.  The biophysics of the variants of sickle-cell disease.

Authors:  R C GRIGGS; J W HARRIS
Journal:  AMA Arch Intern Med       Date:  1956-03

3.  Studies on the destruction of red blood cells. X. The biophysics and biology of sickle-cell disease.

Authors:  J W HARRIS; H H BREWSTER; T H HAM; W B CASTLE
Journal:  AMA Arch Intern Med       Date:  1956-02

4.  Open heart surgery in patients with inherited hemoglobinopathies, red cell dyscrasias, and coagulopathies.

Authors:  M R deLeval; H F Taswell; E J Bowie; G K Danielson
Journal:  Arch Surg       Date:  1974-11

5.  Haemolysis with Björk-Shiley and Starr-Edwards prosthetic heart valves: a comparative study.

Authors:  S D Slater; I A Sallam; W H Bain; M A Turner; T D Lawrie
Journal:  Thorax       Date:  1974-11       Impact factor: 9.139

6.  Haematological evaluation of the Björk-Shiley tilting disc valve prosthesis in isolated aortic valvular disease.

Authors:  V O Björk; A Henze; A Carlström
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1974

7.  Factors influencing hemolysis in valve prosthesis.

Authors:  C Crexells; N Aerichide; Y Bonny; G Lepage; L Campeau
Journal:  Am Heart J       Date:  1972-08       Impact factor: 4.749

8.  Mitral valve replacement in a child with sickle cell anemia.

Authors:  J Craenen; J Kilman; D M Hosier; M Weinberger
Journal:  J Thorac Cardiovasc Surg       Date:  1972-05       Impact factor: 5.209

9.  Aortic homograft replacement of the mitral valve in sickle cell trait.

Authors:  M H Yacoub; J Baron; A Et-Etr; C F Kittle
Journal:  J Thorac Cardiovasc Surg       Date:  1970-04       Impact factor: 5.209

10.  Chronic hemolysis following mitral valve replacement. A comparative study of the Björk-Shiley, composite-seat Starr-Edwards, and frame-mounted aortic homograft valves.

Authors:  R Ahmad; S M Manohitharajah; P B Deverall; D A Watson
Journal:  J Thorac Cardiovasc Surg       Date:  1976-02       Impact factor: 5.209
  10 in total
  4 in total

1.  Sickle cell disease and aortic valve replacement: use of cardiopulmonary bypass, partial exchange transfusion, platelet sequestration, and continuous hemofiltration.

Authors:  S W Sutton; E K Hunley; M A Duncan; R Rodriguez; T P Meyers
Journal:  Tex Heart Inst J       Date:  1999

Review 2.  Sickle cell states and the anaesthetist.

Authors:  D W Esseltine; M R Baxter; J C Bevan
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

3.  Mitral valve replacement using cold cardioplegia in a patient with sickle cell trait.

Authors:  I Hudson; I A Davidson; C G McGregor
Journal:  Thorax       Date:  1981-02       Impact factor: 9.139

4.  Open-heart surgery in sickle-cell haemoglobinopathies: report of 15 cases.

Authors:  D Métras; A O Coulibaly; K Ouattara; A Longechaud; P Millet; J Chauvet
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.